Total Funding: $102.5M
Headquarters: Abingdon, Oxfordshire, United Kingdom
Funding Status: N/A
Employee Number: 51-100
Estimated Revenue: $10M to $50M
Investment Stage: N/A
Last Funding Type: Venture - Series Unknown
Number Of Exists: Venture - Series Unknown
Technology: Cancer
Investor Type: Company
Investors Number: 7
Founded Date: 2006
Industry: Gene Therapy